Use of the Comet Assay to Detect Hypoxic Cells in Murine Tumours and Normal Tissues Exposed to Bioreductive Drugs
Open Access
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 34 (3) , 301-305
- https://doi.org/10.3109/02841869509093979
Abstract
The alkaline comet assay was applied to individual cells from mice exposed to two bioreductive drugs, tirapazamine and RSU 1069, with the goal of comparing DNA damage to tumours and normal tissues. More DNA single-strand breaks (SSBs) and a greater heterogeneity in DNA damage were observed in tumour cells than in spleen and marrow cells of mice exposed to 10–100 mg/kg tirapazamine, consistent with the presence of hypoxic cells and the greater bioreductive capacity of tumours. In mice injected with 25–200 mg/kg RSU 1069, aerobic cells exhibited large numbers of SSBs while toxic DNA interstrand crosslinks were produced only in hypoxic cells. Cells from bone marrow and spleen showed extensive numbers of SSBs, but minimal crosslinking compared to tumours where 10–20% of cells were heavily crosslinked. DNA damage produced by these two bioreductive drugs may be useful in estimating the range of individual cell oxygen contents within tumours and normal tissues.Keywords
This publication has 19 references indexed in Scilit:
- Radiation-induced reoxygenation in the SCCVII murine tumour: evidence for a decrease in oxygen consumption and an increase in tumour perfusionRadiotherapy and Oncology, 1994
- SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumoursBritish Journal of Cancer, 1993
- Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studiesBritish Journal of Cancer, 1993
- Detection of Hypoxic cells in a Murine Tumour With the Use of the Comet AssayJNCI Journal of the National Cancer Institute, 1992
- Molecular mechanisms for the hypoxiadependent activation of 3-amino-1,2,4-benzotriazine-1, 4-dioxide (SR 4233)Biochemical Pharmacology, 1988
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Studies on the toxicity of RSU-1069International Journal of Radiation Oncology*Biology*Physics, 1986
- RSU 1069, a nitroimidazole containing an aziridine groupBiochemical Pharmacology, 1986
- Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069International Journal of Radiation Oncology*Biology*Physics, 1984
- Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cellsBiochemical and Biophysical Research Communications, 1984